Invesco Ltd. Sells 32,859 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

Invesco Ltd. reduced its stake in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 14.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 201,652 shares of the company's stock after selling 32,859 shares during the period. Invesco Ltd. owned 0.50% of Phibro Animal Health worth $4,235,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of PAHC. Barclays PLC boosted its position in Phibro Animal Health by 25.7% in the 3rd quarter. Barclays PLC now owns 143,337 shares of the company's stock valued at $3,228,000 after buying an additional 29,271 shares during the period. Geode Capital Management LLC increased its stake in shares of Phibro Animal Health by 5.7% during the third quarter. Geode Capital Management LLC now owns 507,469 shares of the company's stock worth $11,430,000 after acquiring an additional 27,201 shares during the period. SG Americas Securities LLC lifted its holdings in Phibro Animal Health by 7.4% in the fourth quarter. SG Americas Securities LLC now owns 13,162 shares of the company's stock valued at $276,000 after acquiring an additional 906 shares during the period. Inspire Investing LLC acquired a new stake in shares of Phibro Animal Health in the 4th quarter worth approximately $791,000. Finally, Smith Group Asset Management LLC acquired a new stake in Phibro Animal Health in the 4th quarter valued at about $541,000. Institutional investors own 99.34% of the company's stock.

Phibro Animal Health Stock Performance

Phibro Animal Health stock traded up $0.45 during midday trading on Tuesday, hitting $18.88. The company's stock had a trading volume of 142,439 shares, compared to its average volume of 192,705. The company has a 50-day moving average price of $20.54 and a two-hundred day moving average price of $22.10. The company has a market cap of $764.70 million, a price-to-earnings ratio of 39.33, a PEG ratio of 0.45 and a beta of 0.63. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.37. Phibro Animal Health Co. has a 1-year low of $13.34 and a 1-year high of $26.55.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a net margin of 1.75% and a return on equity of 25.35%. As a group, sell-side analysts predict that Phibro Animal Health Co. will post 1.95 earnings per share for the current year.

Phibro Animal Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th were issued a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, March 5th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.54%. Phibro Animal Health's dividend payout ratio is currently 100.00%.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the company. StockNews.com cut Phibro Animal Health from a "buy" rating to a "hold" rating in a report on Tuesday, March 25th. Morgan Stanley set a $20.00 price objective on Phibro Animal Health in a research note on Tuesday, April 15th. Finally, Barclays upped their price target on shares of Phibro Animal Health from $20.00 to $22.00 and gave the stock an "underweight" rating in a research note on Monday, February 10th. Two analysts have rated the stock with a sell rating and three have given a hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $19.75.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.